Posted by admin on May 24th, 2022

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.35-$2.55 for the period, compared to the consensus estimate of $2.77. The company issued revenue guidance of $4.10 billion-$4.20 billion, compared to the consensus revenue estimate of $4.23 billion.

Several equities research analysts have recently weighed in on the stock. HC Wainwright reduced their target price on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a hold rating on the stock in a research note on Friday, April 22nd. Credit Suisse Group reduced their price target on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an outperform rating on the stock in a research note on Tuesday, March 1st. Piper Sandler reaffirmed a neutral rating and issued a $46.00 price target (down previously from $71.00) on shares of DENTSPLY SIRONA in a research note on Wednesday, April 20th. StockNews.com raised shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Wednesday, May 18th. Finally, The Goldman Sachs Group reduced their price target on shares of DENTSPLY SIRONA from $59.00 to $47.00 and set a neutral rating on the stock in a research note on Thursday, April 21st. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of Hold and a consensus target price of $52.89.

NASDAQ XRAY opened at $38.50 on Tuesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. The company has a market capitalization of $8.29 billion, a price-to-earnings ratio of 22.78 and a beta of 0.94. The company’s 50-day simple moving average is $44.33 and its two-hundred day simple moving average is $50.31. DENTSPLY SIRONA has a one year low of $35.00 and a one year high of $68.02.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $9.67 billion for the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The company’s revenue for the quarter was up 841.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.72 EPS. Equities analysts expect that DENTSPLY SIRONA will post 2.41 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, April 8th. Stockholders of record on Friday, March 25th were issued a $0.125 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date was Thursday, March 24th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 29.59%.

In other news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the sale, the director now directly owns 35,155 shares in the company, valued at approximately $1,396,005.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.76% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust boosted its stake in DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 568 shares in the last quarter. Covestor Ltd boosted its stake in DENTSPLY SIRONA by 97.8% in the 1st quarter. Covestor Ltd now owns 3,198 shares of the medical instruments supplier’s stock worth $157,000 after purchasing an additional 1,581 shares in the last quarter. KB Financial Partners LLC boosted its stake in DENTSPLY SIRONA by 19.5% in the 1st quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock worth $219,000 after purchasing an additional 726 shares in the last quarter. Captrust Financial Advisors boosted its stake in DENTSPLY SIRONA by 14.0% in the 1st quarter. Captrust Financial Advisors now owns 4,446 shares of the medical instruments supplier’s stock worth $219,000 after purchasing an additional 546 shares in the last quarter. Finally, SkyView Investment Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $228,000. Institutional investors and hedge funds own 94.79% of the company’s stock.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Omega Therapeutics (NASDAQ:OMGA) Downgraded to “Hold” at Zacks Investment Research

Polaris Inc. (NYSE:PII) Given Average Recommendation of “Hold” by Analysts